Crossref journal-article
Elsevier BV
Journal of the Neurological Sciences (78)
Bibliography

Martignoni, E., Tassorelli, C., Nappi, G., Zangaglia, R., Pacchetti, C., & Blandini, F. (2007). Homocysteine and Parkinson’s disease: A dangerous liaison? Journal of the Neurological Sciences, 257(1–2), 31–37.

Authors 6
  1. E. Martignoni (first)
  2. C. Tassorelli (additional)
  3. G. Nappi (additional)
  4. R. Zangaglia (additional)
  5. C. Pacchetti (additional)
  6. F. Blandini (additional)
References 77 Referenced 48
  1. 10.1016/j.advenzreg.2003.11.012 / Adv Enzyme Regul / Methylation demand and homocysteine metabolism. by Stead (2004)
  2. 10.1016/S0166-2236(03)00032-8 / Trends Neurosci / Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders by Mattson (2003)
  3. 10.1146/annurev.nutr.19.1.217 / Annu Rev Nutr / Homocysteine metabolism by Selhub (1999)
  4. 10.1002/jcp.1041460108 / J Cell Physiol / Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of non-transformed, transformed, proliferating, and quiescent cells in culture by Christensen (1991)
  5. 10.1042/bj2980415 / Biochem J / Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism by Miller (1994)
  6. 10.1007/s002340050119 / Neuroradiology / Hyperhomocysteinaemia; with reference to its neuroradiological aspects by van den (1995)
  7. 10.1002/ajmg.1320340320 / Am J Med Genet / Functional methionine synthase deficiency (cblE and cblG): clinical and biochemical heterogeneity by Watkins (1989)
  8. 10.1023/A:1018675624181 / J Thromb Thrombolysis / Homocysteine and risk of cardiovascular disease by Andreotti (2000)
  9. 10.1016/S0140-6736(05)65956-9 / Lancet / Serum total homocysteine concentration and risk of stroke by Perry (1996)
  10. 10.1345/aph.18457 / Ann Pharmacother / Homocysteine as a risk factor for atherosclerosis by Temple (2000)
  11. 10.1042/bst022341s / Biochem Soc Trans / Homocysteine induced endothelial cell toxicity and its protection by Blundell (1994)
  12. 10.1016/0021-9150(95)05730-7 / Atherosclerosis / Homocysteine mediated endothelial cell toxicity and its amelioration by Blundell (1996)
  13. 10.1097/00007890-200202270-00034 / Transplantation / Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients by Abdelfatah (2002)
  14. 10.1172/JCI118776 / J Clin Invest / The oxidant stress of hyperhomocyst(e)inemia by Loscalzo (1996)
  15. 10.1002/jcb.1175 / J Cell Biochem / Aru GM, Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function by Mujumdar (2001)
  16. 10.1161/01.HYP.0000127914.94292.76 / Hypertension / Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways by Suhara (2004)
  17. 10.1096/fj.00-0848com / FASEB J / Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to gamma-glutamyl transpeptidase activity by Bessede (2001)
  18. 10.1074/jbc.M100747200 / J Biol Chem / Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response by Zhang (2001)
  19. 10.1523/JNEUROSCI.20-18-06920.2000 / J Neurosci / Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity by Kruman (2000)
  20. 10.1016/0167-5699(94)90018-3 / Immunol Today / Oxidative stress as a mediator of apoptosis by Buttke (1994)
  21. 10.1080/10715760400017269 / Free Radic Res / No evidence for oxidative stress as a mechanism of action of hyperhomocysteinemia in humans by Huerta (2004)
  22. 10.1111/j.1432-1033.2004.04070.x / Eur J Biochem / Effects of homocysteine on apoptosis-related proteins and anti-oxidant systems in isolated human lymphocytes by Mangiagalli (2004)
  23. 10.1093/jn/128.7.1204 / J Nutr / Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women by Jacob (1998)
  24. 10.1080/07315724.1998.10718790 / J Am Coll Nutr / Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis by Siri (1998)
  25. 10.1038/ng0595-111 / Nat Genet / A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase by Frosst (1995)
  26. 10.1089/ars.2005.7.813 / Antioxid Redox Signal / The role of cystathionine beta-synthase in homocysteine metabolism by Jhee (2005)
  27. 10.1161/01.CIR.94.12.3074 / Circulation / Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease by Deloughery (1996)
  28. 10.1161/01.CIR.94.10.2410 / Circulation / Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians by Ma (1996)
  29. 10.1182/asheducation-2003.1.62 / Hematology (Am Soc Hematol Educ Program) / Update on cobalamin, folate, and homocysteine by Carmel (2003)
  30. 10.1016/j.pnpbp.2005.06.025 / Prog Neuropsychopharmacol Biol Psychiatry / The central nervous system in animal models of hyperhomocysteinemia by Troen (2005)
  31. {'key': '10.1016/j.jns.2007.01.028_bib31', 'first-page': '1894', 'article-title': 'Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats', 'volume': '55', 'author': 'Pogribny', 'year': '1995', 'journal-title': 'Cancer Res'} / Cancer Res / Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats by Pogribny (1995)
  32. {'key': '10.1016/j.jns.2007.01.028_bib32', 'first-page': '2071s', 'article-title': 'Methyl groups in carcinogenesis: effects on DNA methylation and gene expression', 'volume': '52', 'author': 'Wainfan', 'year': '1992', 'journal-title': 'Cancer Res'} / Cancer Res / Methyl groups in carcinogenesis: effects on DNA methylation and gene expression by Wainfan (1992)
  33. {'key': '10.1016/j.jns.2007.01.028_bib33', 'first-page': '471', 'article-title': 'Hyperhomocysteinemia: a new risk factor for degenerative diseases', 'volume': '48', 'author': 'Herrmann', 'year': '2002', 'journal-title': 'Clin Lab'} / Clin Lab / Hyperhomocysteinemia: a new risk factor for degenerative diseases by Herrmann (2002)
  34. 10.1515/znc-1995-9-1017 / Z Naturforsch [C] / Homocysteine-induced oxidative damage: mechanisms and possible roles in neurodegenerative and atherogenic processes by Schlussel (1995)
  35. 10.1016/S0163-7258(96)00097-6 / Pharmacol Ther / The neurotransmitter candidature of sulphur-containing excitatory amino acids in the mammalian central nervous system by Thompson (1996)
  36. 10.1002/jnr.10416 / J Neurosci Res / Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage by Ho (2002)
  37. 10.1523/JNEUROSCI.22-05-01752.2002 / J Neurosci / Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease by Kruman (2002)
  38. 10.1073/pnas.94.11.5923 / Proc Natl Acad Sci U S A / Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor by Lipton (1997)
  39. 10.1046/j.0022-3042.2001.00676.x / J Neurochem / Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease by Duan (2002)
  40. 10.1007/BF00969090 / Neurochem Res / The effects of l-dopa on the activity of methionine adenosyltransferase: relevance to l-dopa therapy and tolerance by Benson (1993)
  41. 10.1097/00002826-199702000-00007 / Clin Neuropharmacol / Effect of l-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats by Miller (1997)
  42. 10.1016/S0024-3205(00)00557-9 / Life Sci / Effects of l-dopa treatment on methylation in mouse brain: implications for the side effects of l-dopa by Liu (2000)
  43. 10.1097/00002826-199702000-00007 / Clin Neuropharmacol / Effect of l-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats by Miller (1997)
  44. {'key': '10.1016/j.jns.2007.01.028_bib44', 'first-page': '527', 'article-title': "Sulfate and cysteine levels in the plasma of patients with Parkinson's disease", 'volume': '16', 'author': 'Allain', 'year': '1995', 'journal-title': 'Neurotoxicology'} / Neurotoxicology / Sulfate and cysteine levels in the plasma of patients with Parkinson's disease by Allain (1995)
  45. 10.1159/000007984 / Eur Neurol / Elevated plasma levels of homocysteine in Parkinson's disease by Kuhn (1998)
  46. 10.1001/archneur.60.1.59 / Arch Neurol / Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease by Rogers (2003)
  47. 10.1002/mds.20253 / Mov Disord / Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease by O'suilleabhain (2004)
  48. 10.1001/archneur.61.6.865 / Arch Neurol / Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations by O'suilleabhain (2004)
  49. 10.1111/j.1468-1331.2004.00973.x / Eur J Neurol / Hyperhomocysteinemia in l-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration by Lamberti (2005)
  50. 10.1016/j.parkreldis.2004.07.008 / Parkinsonism Relat Disord / Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications by Zoccolella (2005)
  51. 10.1093/clinchem/47.6.1102 / Clin Chem / Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease by Blandini (2001)
  52. 10.1016/S0140-6736(99)01660-8 / Lancet / Nigral endothelial dysfunction, homocysteine, and Parkinson's disease by Muller (1999)
  53. 10.1016/S0304-3940(01)01972-3 / Neurosci Lett / Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease by Muller (2001)
  54. 10.1152/ajprenal.00465.2004 / Am J Physiol Renal Physiol / Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers. by Fux (2005)
  55. 10.4088/JCP.v66n1210 / J Clin Psychiatry / High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia by Lerner (2005)
  56. 10.1176/appi.ajp.161.9.1705 / Am J Psychiatry / Folate, homocysteine, and negative symptoms in schizophrenia by Goff (2004)
  57. 10.1176/appi.ajp.162.7.1387-a / Am J Psychiatry / The significance of homocysteine levels in schizophrenia by O’Donnell (2005)
  58. 10.1176/appi.ajp.162.7.1388 / Am J Psychiatry / Letter to the editor by Goff (2005)
  59. 10.1002/ana.20509 / Ann Neurol / Methylenetetrahydrofolate reductase C677T genotype and PD by de Lau (2005)
  60. 10.1007/s00702-002-0758-8 / J Neural Transm / Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease by Widner (2002)
  61. 10.1016/j.amjmed.2005.01.052 / Am J Med / Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease by Sato (2005)
  62. 10.1016/0009-8981(73)90429-4 / Clin Chim Acta / The reaction of homocysteine with aldehyde: an explanation of the collagen defects in homocystinuria by Jackson (1973)
  63. 10.1212/01.wnl.0000183063.99107.5c / Neurology / Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease by Irizarry (2005)
  64. 10.1074/jbc.M112372200 / J Biol Chem / Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein by Sai (2002)
  65. 10.1016/S0014-5793(03)00277-1 / FEBS Lett / Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? by Scarpa (2003)
  66. 10.1093/ajcn/82.3.627 / Am J Clin Nutr / High homocysteine and low B vitamins predict cognitive decline in aging men; the Veterans Affairs Normative Aging Study by Tucker (2005)
  67. 10.1016/j.amjmed.2004.08.019 / Am J Med / Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging by Kado (2005)
  68. 10.1093/ajcn/82.4.866 / Am J Clin Nutr / Homocysteine, vitamin B12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study by Mooijaart (2005)
  69. 10.1002/mds.20667 / Mov Disord / Homocysteine and serum markers if immune activation in primary dystonia by Muller (2005)
  70. 10.1254/jphs.CRJ05003X / J Pharmacol Sci / The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins by Hamed (2005)
  71. 10.1016/j.seizure.2005.11.002 / Seizure / Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6 by Sener (2006)
  72. 10.1093/ajcn/82.6.1320 / Am J Clin Nutr / Westendorp Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease by Stott (2005)
  73. 10.1016/j.archger.2005.10.002 / Arch Gerontol Geriatr / Effects of folic acid supplementation on psychomotor performance and hemorheology in healthy elderly subjects by Pathansali (2006)
  74. 10.1212/01.WNL.0000158476.74580.A8 / Neurology / Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment by Boxer (2005)
  75. 10.1212/01.WNL.0000137886.74175.5A / Neurology / Homocysteine and l-Dopa: should Parkinson disease patients receive preventive therapy? by Postuma (2004)
  76. 10.1093/aje/kwh213 / Am J Epidemiol / Folate intake and risk of Parkinson's disease by Chen (2004)
  77. 10.1111/j.1365-277X.2004.00532.x / J Hum Nutr Diet / A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly by Ellinson (2004)
Dates
Type When
Created 18 years, 6 months ago (March 2, 2007, 12:46 p.m.)
Deposited 5 years, 4 months ago (April 20, 2020, 5:10 a.m.)
Indexed 2 months ago (June 30, 2025, 12:25 p.m.)
Issued 18 years, 3 months ago (June 1, 2007)
Published 18 years, 3 months ago (June 1, 2007)
Published Print 18 years, 3 months ago (June 1, 2007)
Funders 0

None

@article{Martignoni_2007, title={Homocysteine and Parkinson’s disease: A dangerous liaison?}, volume={257}, ISSN={0022-510X}, url={http://dx.doi.org/10.1016/j.jns.2007.01.028}, DOI={10.1016/j.jns.2007.01.028}, number={1–2}, journal={Journal of the Neurological Sciences}, publisher={Elsevier BV}, author={Martignoni, E. and Tassorelli, C. and Nappi, G. and Zangaglia, R. and Pacchetti, C. and Blandini, F.}, year={2007}, month=jun, pages={31–37} }